TAIHO PHARMA

We strive to
improve human
health and contribute
to a society enriched
by smiles

About Taiho

Becoming a truly global specialty pharma that meets the expectations of patients worldwide.

Our Business

Taiho Pharmaceutical creates innovative, highly valuable new drugs to support patients and the advancement of medicine, seeking to contribute to smiles and health for people all around the world.

News Releases

September 24, 2019

Taiho Pharmaceutical to Support the Pink Ribbon Campaign Again in 2019
September 20, 2019

Taiho Pharmaceutical Obtains Approval of Additional Dosage and Administration for Breast Cancer in Japan for Antitumor Agent ABRAXANE^® I.V. Infusion 100 mg
September 06, 2019

LONSURF^® (trifluridine/tipiracil) Receives Marketing Authorization in Europe for Previously Treated Metastatic Gastric Cancer
September 06, 2019

Taiho Pharmaceutical Obtains Approval of Anticancer Agent TAS-102 (brand name in Japan "Lonsurf_®") in China for Treatment of Colorectal Cancer
August 29, 2019

Taiho Pharmaceutical Invests in New Venture Capital Fund

Information

July 12, 2018

Announcement of Support from Otsuka Holdings and Its Group Companies in the Aftermath of Severe Storms in Japan（PDF：165.9 KB）